Individual Study / INTER99

INTER99: randomized non-pharmacological INTERvention study for prevention of ischaemic heart disease

INTER99: randomized non-pharmacological INTERvention study for prevention of ischaemic heart disease

INTER99 logo
Initiatives -
To assess the effect on ischaemic heart disease (IHD) incidence of individually tailored non-pharmacological intervention on lifestyle using a newly developed computer-based health educational tool.
Start Year
1999
Funding
Danish Research Councils, Health Foundation, Danish Centre for Evaluation and Health Technology Assessment, Copenhagen County, Danish Heart Foundation, Ministry of Health and Prevention, Association of Danish Pharmacies, Augustinus Foundation, Novo Nordisk, Velux Foundation, Becket Foundation, and Ib Henriksens Foundation.
Visit INTER99

Members

Download
Investigators Contacts
  • Director Torben Jørgensen
    Glostrup Hospital

Design

Study design
Population cohort
Follow Up
Among 5978 people eligible at five year follow-up (59 died and 54 emigrated), 4028 (67.4%) attended. A total of 3163 people died in the 10 year follow-up period.

Marker Paper

Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil. 2003;10(5):377-386. doi:10.1097/01.hjr.0000096541.30533.82

PUBMED 14663300

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
59,616
Number of participants with biosamples
Supplementary Information
Aged 30-60 years

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

By contacting the study representative